Skin Cancer
Tawbi Discusses the Role of Brain Metastases and PD-L1 Status in Melanoma
September 11th 2024During a Case-Based Roundtable® event, Hussein A. Tawbi, MD, PhD, and participants look at benefits of nivolumab combinations for brain metastases and PD-L1 positivity in the metastatic melanoma population in the second article of a 2-part series.
Read More